SJ Keely, KE Barrett - American Journal of Physiology …, 2022 - journals.physiology.org
One of the primary functions of the intestinal epithelium is to transport fluid and electrolytes to and from the luminal contents. Under normal circumstances, absorptive and secretory …
L de Souza Goncalves, T Chu, R Master… - The Journal of …, 2024 - Am Soc Clin Investig
Cholera is a global health problem with no targeted therapies. The Ca2+-sensing receptor (CaSR) is a regulator of intestinal ion transport and a therapeutic target for diarrhea, and …
Small molecule receptor tyrosine kinase inhibitors (SM-TKIs) are among a group of targeted cancer therapies, intended to be more specific to cancer cells compared with treatments …
E De Poel, S Spelier, MC Hagemeijer… - Journal of Cystic …, 2023 - Elsevier
Background Preclinical cell-based assays that recapitulate human disease play an important role in drug repurposing. We previously developed a functional forskolin induced …
E Ishikawa, Y Yokoyama, H Chishima, H Kasai… - Investigational new …, 2023 - Springer
Background: Potential novel strategies for adverse event (AE) management of osimertinib therapy, including therapeutic drug monitoring and the use of biomarkers, have not yet been …
AS Verkman, LJV Galietta - American Journal of Physiology …, 2021 - journals.physiology.org
Chloride transport across cell membranes is broadly involved in epithelial fluid transport, cell volume and pH regulation, muscle contraction, membrane excitability, and organellar …
D Cárdenas-Fernández… - Therapeutic …, 2023 - journals.sagepub.com
The identification of Epidermal Growth Factor Receptor (EGFR) mutations in lung adenocarcinoma has facilitated the development of personalized medicine based on …
SC Guo, B Yu, Q Jia, HY Yan, LQ Wang, FF Sun… - Journal of …, 2024 - Elsevier
Abstract Ethnopharmacological relevance Resina Draconis (RD) is the red resin of Dracaena cochinchinensis (Lour.) SC Chen and most used as a hemostatic drug in …
Epidermal growth factor receptor tyrosine kinase inhibitors (EGFr TKIs) are first‐line therapies for various cancers, and cause dose‐limiting severe diarrhea in many patients. We …